The new approach to naming COVID-19 variants utilizes the Greek alphabet.
New Naming System for COVID-19 Variants
With each new variant of COVID-19 comes new concern for increased transmissibility, impact to vaccination efficacy, and severity of disease. Every time a new variant is identified, those questions linger, with us more commonly finding impacts to transmissibility. As new variants are identified, the naming can sometimes create confusion for communicating them, which often results in a variant being referred to in terms of the area it was identified from, which is a practice we should be moving away from. This week though, the World Health Organization (WHO) released a new labeling strategy for the variants. This new approach utilizes the Greek alphabet to communicate variants. For example, the current variant of concern gaining a lot of attention, B.1.617.2 is now labeled Delta. Hopefully, this will encourage a move away from the haphazard use of the country of origin, which fuels cultural and racial stigma.
Testing, Breakthrough Infections, and Normalizing Things
As more people in the United States get vaccinated, we’re moving to a point of identifying breakthrough infections. These infections are expected, not surprising, and can give us helpful
Saskia v. Popescu, PHD, MPH, MA, CIC
insight into the vaccines and even variants. For some industries, like professional sports and entertainment, where routine surveillance testing is done, it’s not surprising that we would see more cases – we’re looking for them! As Katherine Wu, PhD, noted in the Atlantic: “Breakthroughs can offer a unique wellspring of data. Ferreting them out will help researchers confirm the effectiveness of COVID-19 vaccines, detect coronavirus variants that could evade our immune defenses, and estimate when we might need our next round of shots—if we do at all.” It often seems that when these infections occur, people are wholly surprised. It’s important that we communicate the efficacy of the COVID-19 vaccine in a transparent manner that informs people of such possibilities, but also the benefits of vaccination. Breakthrough infections will continue to occur—so now is the time to address them head-on so that people are not panicked, but also as a reminder that even if you are vaccinated, testing is still an important option following symptoms or even a high-risk exposure.
Lab Leak Theory for COVID-19 Origin Might Mask Racism
We don’t often wade into the “origin” aspect of diseases within the infection prevention world, but with so much swirl, it’s important to share some insight into this debate. Despite no real updates, the divisive and politicized origin of SARS-CoV-2 has come up again in the news. For some diseases, we struggle to truly identify their source—we’ve known about Ebola virus disease since 1976 and still have many questions. Most scientists note that there is an extremely low chance COVID-19 escaped from a Chinese lab and all indicators point to natural origin, emphasizing the racism that often follows media attention to this theory. Researchers though are warning caution over such allegations and the impact to global collaborations. Perhaps one of the most important lessons though is that none of this changes the inherent failures that impacted our response. Our gaps, vulnerabilities, and hurdles to response that have led to nearly 600,000 deaths and millions of cases … these are the issues we should focus on.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.